BIOATLA, INC. Fair Value Adjustment of Warrants
BIOATLA, INC. (BCAB) reported Fair Value Adjustment of Warrants of -$2.89 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-13
- BIOATLA, INC. fair value adjustment of warrants for the quarter ending 2026-06-30 was -$220.00K, a 174.07% decline year-over-year.
- BIOATLA, INC. fair value adjustment of warrants for the quarter ending 2026-03-31 was -$2.67M.
- BIOATLA, INC. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$831.00K.
- BIOATLA, INC. fair value adjustment of warrants for the quarter ending 2025-09-30 was $2.12M.
- BIOATLA, INC. fair value adjustment of warrants for fiscal 2025 was -$295.00K.
- BIOATLA, INC. fair value adjustment of warrants for fiscal 2024 was -$807.00K.
- BIOATLA, INC. fair value adjustment of warrants for fiscal 2023 was $0.00.
- BIOATLA, INC. fair value adjustment of warrants for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$220.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$2.89M 10-Q · filed 2026-08-13 | -$3.73M derived: sum of 3 quarters · filed 2026-08-13 | -$1.61M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$2.67M 10-Q · filed 2026-05-15 | -$3.50M derived: sum of 2 quarters · filed 2026-05-15 | -$1.39M derived: sum of 3 quarters · filed 2026-05-15 | -$1.09M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$831.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.29M derived: sum of 2 quarters · filed 2026-03-31 | $1.58M derived: sum of 3 quarters · filed 2026-08-13 | -$295.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.42M derived: sum of 2 quarters · filed 2026-08-13 | $536.00K 10-Q · filed 2025-11-13 | -$271.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $297.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.58M 10-Q · filed 2026-08-13 | -$2.39M derived: sum of 3 quarters · filed 2026-08-13 | -$2.39M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$1.88M 10-Q · filed 2026-05-15 | -$2.69M derived: sum of 2 quarters · filed 2026-05-15 | -$2.69M derived: sum of 3 quarters · filed 2026-05-15 | -$2.69M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$807.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$807.00K derived: sum of 2 quarters · filed 2026-03-31 | -$807.00K derived: sum of 3 quarters · filed 2026-03-31 | -$807.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-28 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-13 | $0.00 10-Q · filed 2021-08-13 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $853.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $853.00K derived: sum of 3 quarters · filed 2022-02-28 | $1.63M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $853.00K derived: sum of 2 quarters · filed 2022-02-28 | $1.63M derived: sum of 3 quarters · filed 2022-02-28 | $1.58M 10-K · filed 2022-02-28 |
| 2020-09-30 | $853.00K 10-Q · filed 2021-11-15 | $1.63M derived: sum of 2 quarters · filed 2021-11-15 | $1.58M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $775.00K 10-Q · filed 2021-08-13 | $728.00K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $47.00K 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $63.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |